Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
January 13, 2009
Dextromethorphan/quinidine sulfate for pseudobulbar affect
Howard Rosen
Missouri Medicine
|
October 17, 2018
Is Obesity A Disease or A Behavior Abnormality? Did the AMA Get It Right?
Howard Rosen
Idrugs : the Investigational Drugs Journal
|
April 8, 2010
AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain
Nicholas Olney, Howard Rosen
Current Treatment Options in Cardiovascular Medicine
|
June 28, 2008
The causes and treatment of pseudobulbar affect in ischemic stroke
Preethi Balakrishnan, Howard Rosen
Nature Reviews. Drug Discovery
|
May 3, 2005
The rise and rise of drug delivery
Howard Rosen, Thierry Abribat
Advances in Experimental Medicine and Biology
|
January 12, 2021
Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations
Bradley F Boeve, Howard Rosen
Continuum (Minneapolis, Minn.)
|
July 20, 2012
Neuroimaging in dementia
Maria Carmela Tartaglia, Paolo Vitali, Raffaella Migliaccio, et al.
Neuroimage
|
November 1, 2011
MRI patterns of atrophy and hypoperfusion associations across brain regions in frontotemporal dementia
Duygu Tosun, Howard Rosen, Bruce L Miller, et al.
American Journal of Community Psychology
|
May 1, 2014
Top-down, bottom-up, and around the jungle gym: a social exchange and networks approach to engaging afterschool programs in implementing evidence-based practices
Emilie Phillips Smith, Eileen Wise, Howard Rosen, et al.
Health Informatics Journal
|
December 22, 2012
Enhancing behavioral health treatment and crisis management through mobile ecological momentary assessment and SMS messaging
Brad Smith, William D Harms, Stephanie Burres, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Drugs of Today (Barcelona, Spain : 1998)
|
January 13, 2009
Dextromethorphan/quinidine sulfate for pseudobulbar affect
Howard Rosen
Missouri Medicine
|
October 17, 2018
Is Obesity A Disease or A Behavior Abnormality? Did the AMA Get It Right?
Howard Rosen
Idrugs : the Investigational Drugs Journal
|
April 8, 2010
AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain
Nicholas Olney, Howard Rosen
Current Treatment Options in Cardiovascular Medicine
|
June 28, 2008
The causes and treatment of pseudobulbar affect in ischemic stroke
Preethi Balakrishnan, Howard Rosen
Nature Reviews. Drug Discovery
|
May 3, 2005
The rise and rise of drug delivery
Howard Rosen, Thierry Abribat
Advances in Experimental Medicine and Biology
|
January 12, 2021
Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations
Bradley F Boeve, Howard Rosen
Continuum (Minneapolis, Minn.)
|
July 20, 2012
Neuroimaging in dementia
Maria Carmela Tartaglia, Paolo Vitali, Raffaella Migliaccio, et al.
Neuroimage
|
November 1, 2011
MRI patterns of atrophy and hypoperfusion associations across brain regions in frontotemporal dementia
Duygu Tosun, Howard Rosen, Bruce L Miller, et al.
American Journal of Community Psychology
|
May 1, 2014
Top-down, bottom-up, and around the jungle gym: a social exchange and networks approach to engaging afterschool programs in implementing evidence-based practices
Emilie Phillips Smith, Eileen Wise, Howard Rosen, et al.
Health Informatics Journal
|
December 22, 2012
Enhancing behavioral health treatment and crisis management through mobile ecological momentary assessment and SMS messaging
Brad Smith, William D Harms, Stephanie Burres, et al.
Page
of 7